Transporters involved in resistance to antimalarial drugs

Trends in Pharmacological Sciences

Volumn 27, Issue 11, 2006, Pages 594-601

  Valderramos, Stephanie G ^a   Fidock, David A ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATASE (CALCIUM); ARTEMETHER PLUS BENFLUMETOL; ARTEMISIN; BENFLUMETOL; CHLOROQUINE; MULTIDRUG RESISTANCE PROTEIN 1;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIMALARIAL ACTIVITY; CARBOXY TERMINAL SEQUENCE; DISEASE CARRIER; DISEASE TRANSMISSION; DRUG ACCUMULATION; DRUG DIFFUSION; DRUG PROTEIN BINDING; DRUG TRANSPORT; ERYTHROCYTE MEMBRANE; GENE MAPPING; GENETIC MANIPULATION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GEOGRAPHIC DISTRIBUTION; IC 50; IN VITRO STUDY; INFECTION RESISTANCE; MALARIA FALCIPARUM; NONHUMAN; PLASMODIUM FALCIPARUM; POINT MUTATION; PREDICTION; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN TRANSPORT; REVIEW; SARCOPLASMIC RETICULUM; SINGLE NUCLEOTIDE POLYMORPHISM; STEADY STATE; TEMPERATURE DEPENDENCE;

ANIMALS; ANTIMALARIALS; ARTEMISININS; CALCIUM-TRANSPORTING ATPASES; CHLOROQUINE; DRUG RESISTANCE; HUMANS; MALARIA, FALCIPARUM; MEMBRANE TRANSPORT PROTEINS; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; PLASMODIUM FALCIPARUM; PROTOZOAN PROTEINS; SESQUITERPENES; SODIUM-HYDROGEN ANTIPORTER;

EID: 33749989605     PISSN: 01656147     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tips.2006.09.005     Document Type: Review

References (77)

1. Greenwood B., and Mutabingwa T. Malaria in 2002. Nature 415 (2002) 670-672
2. Snow R.W., et al. The global distribution of clinical episodes of Plasmodium falciparum malaria. Nature 434 (2005) 214-217
3. Miller L.H., et al. The pathogenic basis of malaria. Nature 415 (2002) 673-679
4. Planche T., and Krishna S. Severe malaria: metabolic complications. Curr. Mol. Med. 6 (2006) 141-153
5. Wellems T.E., and Plowe C.V. Chloroquine-resistant malaria. J. Infect. Dis. 184 (2001) 770-776
6. Uhlemann A.-C., et al. Mechanisms of antimalarial drug action and resistance. In: Sherman I.W. (Ed). Molecular Approaches to Malaria (2005), ASM Press 429-461
7. Wongsrichanalai C., et al. Epidemiology of drug-resistant malaria. Lancet Infect. Dis. 2 (2002) 209-218
8. White N.J. Antimalarial drug resistance. J. Clin. Invest. 113 (2004) 1084-1092
9. Baird J.K. Effectiveness of antimalarial drugs. N. Engl. J. Med. 352 (2005) 1565-1577
10. Eckstein-Ludwig U., et al. Artemisinins target the SERCA of Plasmodium falciparum. Nature 424 (2003) 957-961
11. Jambou R., et al. Resistance of Plasmodium falciparum field isolates to in-vitro artemether and point mutations of the SERCA-type PfATPase6. Lancet 366 (2005) 1960-1963
12. Uhlemann A.C., et al. A single amino acid residue can determine sensitivity of SERCAs to artemisinins. Nat. Struct. Mol. Biol. 12 (2005) 628-629
13. Krishna S., et al. Re-evaluation of how artemisinins work in light of emerging evidence of in vitro resistance. Trends Mol. Med. 12 (2006) 200-205
14. Gregson A., and Plowe C.V. Mechanisms of resistance of malaria parasites to antifolates. Pharmacol. Rev. 57 (2005) 117-145
15. Wiesner J., et al. New antimalarial drugs. Angew. Chem. Int. Ed. Engl. 42 (2003) 5274-5293
16. Su X., et al. Complex polymorphisms in a ∼330 kDa protein are linked to chloroquine-resistant P. falciparum in Southeast Asia and Africa. Cell 91 (1997) 593-603
17. Fidock D.A., et al. Mutations in the P. falciparum digestive vacuole transmembrane protein PfCRT and evidence for their role in chloroquine resistance. Mol. Cell 6 (2000) 861-871
18. Cooper R.A., et al. Alternative mutations at position 76 of the vacuolar transmembrane protein PfCRT are associated with chloroquine resistance and unique stereospecific quinine and quinidine responses in Plasmodium falciparum. Mol. Pharmacol. 61 (2002) 35-42
19. Goldberg D.E. Hemoglobin degradation. Curr. Top. Microbiol. Immunol. 295 (2005) 275-291
20. Bray P.G., et al. Defining the role of PfCRT in Plasmodium falciparum chloroquine resistance. Mol. Microbiol. 56 (2005) 323-333
21. Hyde J.E. Drug-resistant malaria. Trends Parasitol. 21 (2005) 494-498
22. Sidhu A.B., et al. Chloroquine resistance in Plasmodium falciparum malaria parasites conferred by pfcrt mutations. Science 298 (2002) 210-213
23. Lakshmanan V., et al. A critical role for PfCRT K76T in Plasmodium falciparum verapamil-reversible chloroquine resistance. EMBO J. 24 (2005) 2294-2305
24. Johnson D.J., et al. Evidence for a central role for PfCRT in conferring Plasmodium falciparum resistance to diverse antimalarial agents. Mol. Cell 15 (2004) 867-877
25. Chen N., et al. pfcrt allelic types with two novel amino acid mutations in chloroquine-resistant Plasmodium falciparum isolates from the Philippines. Antimicrob. Agents Chemother. 47 (2003) 3500-3505
26. Lim P., et al. pfcrt polymorphism and chloroquine resistance in Plasmodium falciparum strains isolated in Cambodia. Antimicrob. Agents Chemother. 47 (2003) 87-94
27. Sutherland C.J., et al. Gambian children successfully treated with chloroquine can harbour and transmit Plasmodium falciparum gametocytes carrying resistance genes. Am. J. Trop. Med. Hyg. 67 (2002) 578-585
28. Hallett R.L., et al. Combination therapy counteracts the enhanced transmission of drug-resistant malaria parasites to mosquitoes. Antimicrob. Agents Chemother. 48 (2004) 3940-3943
29. Chutmongkonkul M., et al. Plasmodium falciparum: effect of chloroquine, halofantrine and pyrimethamine on the infectivity of gametocytes for Anopheles stephensi mosquitoes. Ann. Trop. Med. Parasitol. 86 (1992) 103-110
30. Wootton J.C., et al. Genetic diversity and chloroquine selective sweeps in Plasmodium falciparum. Nature 418 (2002) 320-323
31. Bray P.G., and Ward S.A. A comparison of the phenomenology and genetics of multidrug resistance in cancer cells and quinoline resistance in Plasmodium falciparum. Pharmacol. Ther. 77 (1998) 1-28
32. Bray P.G., et al. Defining the role of PfCRT in P. falciparum chloroquine resistance. Mol. Microbiol. 56 (2005) 323-333
33. Yayon A. The antimalarial mode of action of chloroquine. Rev. Clin. Basic Pharm. 5 (1985) 99-139
34. Bray P.G., et al. Access to hematin: the basis of chloroquine resistance. Mol. Pharmacol. 54 (1998) 170-179
35. Krogstad D.J., et al. Efflux of chloroquine from Plasmodium falciparum: mechanism of chloroquine resistance. Science 238 (1987) 1283-1285
36. Krogstad D.J., et al. Energy dependence of chloroquine accumulation and chloroquine efflux in Plasmodium falciparum. Biochem. Pharmacol. 43 (1992) 57-62
37. Sanchez C.P., et al. Evidence for a substrate specific and inhibitable drug efflux system in chloroquine resistant Plasmodium falciparum strains. Biochemistry 43 (2004) 16365-16373
38. Sanchez C.P., et al. Trans stimulation provides evidence for a drug efflux carrier as the mechanism of chloroquine resistance in Plasmodium falciparum. Biochemistry 42 (2003) 9383-9394
39. Bennett T.N., et al. Drug resistance-associated pfCRT mutations confer decreased Plasmodium falciparum digestive vacuolar pH. Mol. Biochem. Parasitol. 133 (2004) 99-114
40. Dzekunov S.M., et al. Digestive vacuolar pH of intact intraerythrocytic P. falciparum either sensitive or resistant to chloroquine. Mol. Biochem. Parasitol. 110 (2000) 107-124
41. Ursos L.M., and Roepe P.D. Chloroquine resistance in the malarial parasite, Plasmodium falciparum. Med. Res. Rev. 22 (2002) 465-491
42. Martin R.E., and Kirk K. The malaria parasite's chloroquine resistance transporter is a member of the drug/metabolite transporter superfamily. Mol. Biol. Evol. 21 (2004) 1938-1949
43. Tran C.V., and Saier Jr. M.H. The principal chloroquine resistance protein of Plasmodium falciparum is a member of the drug/metabolite transporter superfamily. Microbiology 150 (2004) 1-3
44. Zhang H., et al. The antimalarial drug resistance protein Plasmodium falciparum chloroquine resistance transporter binds chloroquine. Biochemistry 43 (2004) 8290-8296
45. Naude B., et al. Dictyostelium discoideum expresses a malaria chloroquine resistance mechanism upon transfection with mutant, but not wild-type, Plasmodium falciparum transporter PfCRT. J. Biol. Chem. 280 (2005) 25596-25603
46. Sanchez C.P., et al. Identification of a chloroquine importer in Plasmodium falciparum. Differences in import kinetics are genetically linked with the chloroquine-resistant phenotype. J. Biol. Chem. 272 (1997) 2652-2658
47. Stein W.D. Transport and Diffusion Across Cell Membranes (1986), Academic Press
48. Sanchez C.P., et al. Evidence for a pfcrt-associated chloroquine efflux system in the human malarial parasite Plasmodium falciparum. Biochemistry 44 (2005) 9862-9870
49. Warhurst D.C., et al. Lysosomes and drug resistance in malaria. Lancet 360 (2002) 1527-1529
50. Homewood C.A., et al. Lysosomes, pH and the anti-malarial action of chloroquine. Nature 235 (1972) 50-52
51. Krogstad D.J., et al. Antimalarials increase vesicle pH in Plasmodium falciparum. J. Cell Biol. 101 (1985) 2302-2309
52. Yayon A., et al. Identification of the acidic compartment of Plasmodium falciparum-infected human erythrocytes as the target of the antimalarial drug chloroquine. EMBO J. 3 (1984) 2695-2700
53. Bray P.G., et al. Distribution of acridine orange fluorescence in Plasmodium falciparum-infected erythrocytes and its implications for the evaluation of digestive vacuole pH. Mol. Biochem. Parasitol. 119 (2002) 301-304
54. Wissing F., et al. Illumination of the malaria parasite Plasmodium falciparum alters intracellular pH. Implications for live cell imaging. J. Biol. Chem. 277 (2002) 37747-37755
55. Hayward R., et al. The pH of the digestive vacuole of Plasmodium falciparum is not associated with chloroquine resistance. J. Cell Sci. 119 (2006) 1016-1025
56. Peel S.A. The ABC transporter genes of Plasmodium falciparum and drug resistance. Drug Resist. Updat. 4 (2001) 66-74
57. Duraisingh M.T., and Cowman A.F. Contribution of the pfmdr1 gene to antimalarial drug-resistance. Acta Trop. 94 (2005) 181-190
58. Volkman S.K., et al. Functional complementation of the ste6 gene of Saccharomyces cerevisiae with the pfmdr1 gene of Plasmodium falciparum. Proc. Natl. Acad. Sci. U. S. A. 92 (1995) 8921-8925
59. Rohrbach P., et al. Genetic linkage of pfmdr1 with food vacuolar solute import in Plasmodium falciparum. EMBO J. 25 (2006) 3000-3011
60. Adagut I.S., and Warhust D.C. Plasmodium falciparum: linkage disequilibrium between loci in chromosomes 7 and 5 and chloroquine selective pressure in Northern Nigeria. Parasitology 123 (2001) 219-224
61. Djimdé A., et al. A molecular marker for chloroquine resistant falciparum malaria. N. Engl. J. Med. 344 (2001) 257-263
62. Babiker H.A., et al. High-level chloroquine resistance in Sudanese isolates of Plasmodium falciparum is associated with mutations in the chloroquine resistance transporter gene pfcrt and the multidrug resistance gene pfmdr1. J. Infect. Dis. 183 (2001) 1535-1538
63. Mu J., et al. Multiple transporters associated with malaria parasite responses to chloroquine and quinine. Mol. Microbiol. 49 (2003) 977-989
64. Reed M.B., et al. Pgh1 modulates sensitivity and resistance to multiple antimalarials in Plasmodium falciparum. Nature 403 (2000) 906-909
65. Sidhu A.B., et al. pfmdr1 mutations contribute to quinine resistance and enhance mefloquine and artemisinin sensitivity in Plasmodium falciparum. Mol. Microbiol. 57 (2005) 913-926
66. Ngo T., et al. Analysis of pfcrt, pfmdr1, dhfr, and dhps mutations and drug sensitivities in Plasmodium falciparum isolates from patients in Vietnam before and after treatment with artemisinin. Am. J. Trop. Med. Hyg. 68 (2003) 350-356
67. Price R.N., et al. Mefloquine resistance in Plasmodium falciparum and increased pfmdr1 gene copy number. Lancet 364 (2004) 438-447
68. Sisowath C., et al. In vivo selection of Plasmodium falciparum pfmdr1 86N coding alleles by artemether-lumefantrine (Coartem). J. Infect. Dis. 191 (2005) 1014-1017
69. Myrick A., et al. Mapping of the Plasmodium falciparum multidrug resistance gene 5′-upstream region, and evidence of induction of transcript levels by antimalarial drugs in chloroquine sensitive parasites. Mol. Microbiol. 49 (2003) 671-683
70. Nelson A.L., et al. pfmdr1 genotyping and in vivo mefloquine resistance on the Thai-Myanmar border. Am. J. Trop. Med. Hyg. 72 (2005) 586-592
71. Price R.N., et al. The pfmdr1 gene is associated with a multidrug-resistant phenotype in Plasmodium falciparum from the western border of Thailand. Antimicrob. Agents Chemother. 43 (1999) 2943-2949
72. Price R.N., et al. Molecular and pharmacological determinants of the therapeutic response to artemether-lumefantrine in multidrug-resistant Plasmodium falciparum malaria. Clin. Infect. Dis. 42 (2006) 1570-1577
73. Sidhu A.B.S., et al. Decreasing pfmdr1 copy number in Plasmodium falciparum malaria heightens susceptibility to mefloquine, lumefantrine, halofantrine, quinine, and artemisinin. J. Infect. Dis. 194 (2006) 528-535
74. Uhlemann A.C., et al. Amplification of Plasmodium falciparum multidrug resistance gene 1 in isolates from Gabon. J. Infect. Dis. 192 (2005) 1830-1835
75. Ferdig M.T., et al. Dissecting the loci of low-level quinine resistance in malaria parasites. Mol. Microbiol. 52 (2004) 985-997
76. Anderson T.J., et al. Are transporter genes other than the chloroquine resistance locus (pfcrt) and multidrug resistance gene (pfmdr) associated with antimalarial drug resistance?. Antimicrob. Agents Chemother. 49 (2005) 2180-2188
77. Howard E.M., et al. A novel transporter, pfcrt, confers antimalarial drug resistance. J. Membr. Biol. 190 (2002) 1-8